DEPARTMENT FOR BUSINESS, ENERGY & INDUSTRIAL STRATEGY
Patient-centric supramolecular formulations of new anti-leishmanial drugs for Indian Communities
IATI Identifier: GB-GOV-13-FUND--GCRF-EP_T020490_1